Trial intelligence / Profile preview

Rukeshu Capsule for Mammary Hyperplasia (Phase II)

CTR20130114Phase 2Completed

Sponsor
Xianyang Licai Pharmaceutical
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of xiaoru sanjie in breast hyperplasia, sponsored by Xianyang Licai Pharmaceutical. Started Jun 2015; status: completed.

02

Drugs

xiaoru sanjie
03

Conditions

breast hyperplasia

Beyond the preview

Go deeper on CTR20130114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call